Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
16.56 | 117.69 | -85.93% | 17.56 | -5.68% |
| P/S |
|
0.9547 | 8.16 | -88.3% |
|
|
| P/BV |
|
0.0983 | 3.37 | -97.08% |
|
|
| P/FCF |
|
-35.48 | 160.84 | -122.06% |
|
|
| Ev/Ebitda |
|
22.93 | 52.39 | -56.23% |
|
|
| Ev/S |
|
4.62 | 6.96 | -33.57% |
|
|
| Ev/FCF |
|
-99.63 | 142.77 | -169.79% |
|
|
| E/P |
|
0.035 | 1.47 | -97.62% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.17 | 24.93 | -19.12% | 21.37 | -5.61% |
| ROE |
|
0.7357 | 12.96 | -94.32% |
|
|
| ROA |
|
0.2962 | 6.09 | -95.14% |
|
|
| ROIC |
|
7.62 | 15.56 | -51.03% |
|
|
| ROS |
|
5.76 | 12.55 | -54.11% |
|
|
| ROCE |
|
1.34 | 16.88 | -92.06% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
28.09 | 143.57 | -80.43% | 12.77 | 119.96% |
| Nеt Debt/Ebitda |
|
18.2 | -5.05 | -460.24% |
|
|
| Debt/Ratio |
|
0.2913 | 0.4053 | -28.14% |
|
|
| Debt/Equity |
|
6.78 | 11.8 | -42.5% |
|
|
| Debt/Net Income |
|
98.35 | 147.58 | -33.36% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.65/10
|
2.26 | 1.73 | 30.32% | 8.48 | -73.34% |
| Number of years of dividend growth |
|
0 | 1.07 | -100% |
|
|
| DSI |
|
0.7857 | 0.7807 | 0.6379% |
|
|
| Average dividend growth |
|
-39.83 | -79.6 | -49.96% |
|
|
| Average percentage for 5 years |
|
8.48 | 2.81 | 201.4% |
|
|
| Average percentage for payments |
|
45.08 | 247.07 | -81.75% |
|
|
| Difference from average difference in sector |
|
0.5258 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
-79.53 | 180.62 | -144.03% |
| Growth impulse Ebitda 5 years |
|
-83.31 | 201.95 | -141.25% |
| Growth impulse Net Income 5 years |
|
-89.85 | 160.03 | -156.15% |
| Growth impulse FCF 5 years |
|
-63.3 | 118.65 | -153.35% |
| Growth impulse EPS 5 years |
|
-90.28 | 280.49 | -132.19% |
IP Score
3.25/10
